Farxiga
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
577 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 30 | 17 | 72 | 93 | 47 | 254 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 9 | 14 | 69 | 76 | 33 | 196 |
| Heart failure | D006333 | HP_0001635 | I50 | 3 | 14 | 19 | 27 | 25 | 84 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 2 | 17 | 11 | 11 | 13 | 50 |
| Chronic renal insufficiency | D051436 | — | N18 | 2 | 15 | 9 | 8 | 10 | 41 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 6 | 6 | 9 | 9 | 3 | 31 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 3 | 8 | 5 | 6 | 20 |
| Infarction | D007238 | EFO_0009463 | — | — | 2 | 8 | 5 | 6 | 19 |
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 3 | 5 | 3 | 2 | 14 |
| Coronary artery disease | D003324 | — | I25.1 | 2 | — | 2 | 6 | 3 | 13 |
Show 94 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | 4 | — | — | 4 |
| Weight loss | D015431 | HP_0001824 | — | — | 4 | 2 | — | — | 4 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 2 | 3 | — | — | 3 |
| Left ventricular dysfunction | D018487 | — | — | — | 1 | 1 | — | 1 | 3 |
| Retinal diseases | D012164 | HP_0000479 | H35.9 | — | — | 1 | — | 2 | 3 |
| Catheter ablation | D017115 | — | — | 1 | 1 | 1 | — | — | 2 |
| Unstable angina | D000789 | EFO_1000985 | I20.0 | — | — | 1 | — | 1 | 2 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 1 | — | — | 2 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 1 | — | 1 | 2 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | 1 | — | 1 | 2 |
Show 30 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 3 | — | — | 2 | 5 |
| Cystinuria | D003555 | — | E72.01 | — | 2 | — | — | — | 2 |
| Sleep apnea syndromes | D012891 | HP_0010535 | G47.3 | — | 1 | — | — | 1 | 2 |
| Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 1 | — | — | — | 2 |
| Amyloidosis | D000686 | EFO_1001875 | E85 | — | 1 | — | — | 1 | 2 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | — | 1 | — | — | — | 1 |
| Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | 1 | — | — | — | 1 |
| Aging | D000375 | GO_0007568 | R41.81 | 1 | 1 | — | — | — | 1 |
| Heart disease risk factors | D000082742 | — | — | — | 1 | — | — | — | 1 |
Show 15 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 22 | — | — | — | 1 | 23 |
| Diabetic ketoacidosis | D016883 | EFO_1000897 | — | 1 | — | — | — | 2 | 3 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
| Reperfusion injury | D015427 | — | — | 1 | — | — | — | — | 1 |
| Vascular ring | D000073872 | — | Q25.45 | 1 | — | — | — | — | 1 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 3 | 3 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 3 | 3 |
| Communicable diseases | D003141 | — | — | — | — | — | — | 1 | 1 |
| Body weight changes | D001836 | — | — | — | — | — | — | 1 | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | — | — | — | 1 | 1 |
| Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | — | — | — | — | 1 | 1 |
| Mitochondrial diseases | D028361 | EFO_0000591 | — | — | — | — | — | 1 | 1 |
| Systolic murmurs | D054160 | — | R01.1 | — | — | — | — | 1 | 1 |
| Tricuspid valve insufficiency | D014262 | HP_0005180 | — | — | — | — | — | 1 | 1 |
| Exercise test | D005080 | EFO_0004328 | — | — | — | — | — | 1 | 1 |
Show 6 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use